Applied Ventures — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
Clear Labs develops fully automated next-generation sequencing (NGS) platforms that process genomic data into insights for research and surveillance applications across infectious disease, food safety, and oncology.
BiotechData & InfrastructureDeep TechHealthtechMedical DevicesSan Carlos, US
Sasan Amini(Co-Founder and CEO)inRamin Khaksar(Co-Founder, CSO, and COO)inEdward Fan(Executive Officer)inBrodie Flanders(Executive Officer, Director)Kazutaka Ohno(Executive Officer)Farzad Naimi(Executive Officer, Director)
Co-investorsMenlo VenturesKhosla VenturesNimble VenturesAlumni VenturesCastor VenturesDentsu Ventures+23 more
CREW is a Yale spinout that adds calcium carbonate (ground limestone) to wastewater treatment plants to intensify biological treatment, cut chemical costs, and permanently remove carbon dioxide.
CleantechClimate TechDeep TechNew Haven, US
Joachim Katchinoff(Co-founder & CEO)inNoah Planavsky(Co-Founder & Scientific Advisor)in
Co-investorsAP VenturesBURNT ISLAND VENTURESConnecticut InnovationsCounteract OneEcho River CapitalEmerald Technology Ventures Ag+4 more
Rubi develops biotechnology solutions for sustainable manufacturing in the fashion and textiles industry.
Advanced ManufacturingBiotechCleantechClimate TechNew MaterialsSan Francisco, US
Neeka Mashouf(Co-founder)inLeila Mashouf(Co-founder)in
BoardDaria Hosseinyoun(Director)inRohini Finch(Director)in
Co-investorsAP VenturesClimacticCollaborative FundDarco CapitalJuniperKayak Ventures+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
















.jpeg)